Skip to content
Research Article Open access CC BY 4.0

Clinical Manifestations of Dermatophytoses and its Treatment: A Review

Sumit Meena, Seema Bhadauria

Asian Journal of Biology · pp. 78–89 · Published 25 Jul 2024

10.9734/ajob/2024/v20i7425

Abstract

Dermatophytes can invade the keratinized tissue and cause one of the most common fungal infections, dermatophytoses. Dermatophytoses are present worldwide and it is most common in warm climates. It is caused by dermatophytes that belong to the genera Trichophyton, Epidermophyton and Microsporum. The clinical manifestation and clinical signs of these infections vary according to the infected body part and the specific dermatophytic species. According to the parts of the body that is affected, clinical manifestations of the dermatophytoses are categorized, such as tinea capitis (scalp), tinea barbae (beard area), tinea corporis (skin other than the bearded area, scalp, hands or feet), tinea cruris (groin and perineal areas), tinea pedis (feet), tinea manuum (hands), and tinea unguium (nails). Trichophyton rubrum, T. mentagrophytes, T. tonsurans, Epidermophyton floccosum and Microsporum canis are the main etiological species for dermatophytoses in all over the world. In this review, we discuss the clinical manifestations of dermatophytoses, etiological agents and their treatment by using oral and topical antifungals.

Dermatophytoses clinical manifestation anti-fungal treatment

References (64)

  1. 1 Toward a Novel Multilocus Phylogenetic Taxonomy for the Dermatophytes [DOI]
  2. 2 Updates on the Epidemiology of Dermatophyte Infections [DOI]
  3. 3 Tinea capitis: A current perspective [DOI]
  4. 4 Dermatophytoses in Animals [DOI]
  5. 5 Alarming India‐wide phenomenon of antifungal resistance in dermatophytes: A multicentre study [DOI]
  6. 6 The New Species Concept in Dermatophytes—a Polyphasic Approach [DOI]
  7. 7 Prevalence and Risk Factors of Tinea Unguium and Tinea Pedis in the General Population in Spain [DOI]
  8. 8 Diagnosis and Management of Tinea Infections.
  9. 9 The diagnosis and management of tinea [DOI]
  10. 10 The kerion: an angry tinea capitis [DOI]
  11. 11 Tinea corporis: an updated review [DOI]
  12. 12 Therapy of Skin, Hair and Nail Fungal Infections [DOI]
  13. 13 Luliconazole for the treatment of fungal infections: an evidence-based review [DOI]
  14. 14 Superficial Fungal Infections [DOI]
  15. 15 A clinical and mycological study of dermatophytic infections [DOI]
  16. 16 Major challenges and perspectives in the diagnostics and treatment of dermatophyte infections [DOI]
  17. 17 Newer topical treatments in skin and nail dermatophyte infections [DOI]
  18. 18 Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines [DOI]
  19. 19 Foot Conditions among Homeless Persons: A Systematic Review [DOI]
  20. 20 Tinea corporis, tinea cruris, tinea nigra, and piedra [DOI]
  21. 21 Advances in Topical and Systemic Antifungals [DOI]
  22. 22 Molecular epidemiology of dermatophytosis in Tehran, Iran, a clinical and microbial survey [DOI]
  23. 23 Differential diagnosis of annular lesions.
  24. 24 Prevalence of skin disease in a cohort of shelter-based homeless men [DOI]
  25. 25 Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method [DOI]
  26. 26 Sequenced dermatophyte strains: Growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model [DOI]
  27. 27 Tinea capitis: temporal shift in pathogens and epidemiology [DOI]
  28. 28 Tinea Unguium: Diagnosis and Treatment in Practice [DOI]
  29. 29 Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis [DOI]
  30. 30 Efficacy and safety of terbinafine hydrochloride 1% cream vs. sertaconazole nitrate 2% cream in tinea corporis and tinea cruris: A comparative therapeutic trial [DOI]
  31. 31 Molecular identification and antifungal susceptibility among clinical isolates of dermatophytes in Shiraz, Iran (2017‐2019) [DOI]
  32. 32 Two feet–one hand syndrome: a retrospective multicenter survey [DOI]
  33. 33 Epidemiological Aspects of Dermatophyte Infections in Horses and Cattle [DOI]
  34. 34 Animal ringworm — its aetiology, public health significance and control [DOI]
  35. 35 Eighty‐four consecutive cases of tinea faciei in Siena, a retrospective study (1989–2003) [DOI]
  36. 36 Human pathogenic fungus Trichophyton schoenleinii activates the NLRP3 inflammasome [DOI]
  37. 37 Efinaconazole: Developmental and reproductive toxicity potential of a novel antifungal azole [DOI]
  38. 38 Clinical types of tinea capitis and species identification in children: an experience from tertiary care centres of Karachi, Pakistan.
  39. 39 The Epidemiology of Tinea Manuum in Nanchang Area, South China [DOI]
  40. 40 Comparison of Topical Anti- Fungal Agents Sertaconazole and Clotrimazole in the Treatment of Tinea Corporis-An Observational Study [DOI]
  41. 41 From animal to man: Tinea barbae [DOI]
  42. 42 Tinea corporis caused by Trichophyton equinum in a rider and review of the literature [DOI]
  43. 43 Broad spectrum antidermatophytic drug for the control of tinea infection in human beings [DOI]
  44. 44 Epidemiology of dermatophytoses in 31 municipalities of the province of Buenos Aires, Argentina: A 6-year study [DOI]
  45. 45 A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris.
  46. 46 Tinea Faciei - Hypo Diagnosed Facial Dermatoses [DOI]
  47. 47 Dermatophytes from Animals. [DOI]
  48. 48 Treatment of Signs and Symptoms (Pruritus) of Interdigital Tinea Pedis With Econazole Nitrate Foam, 1.
  49. 49 Clinical Manifestations of Dermatophytoses: A Review
  50. 50 Dermatophyte infections [DOI]
  51. 51 Current Topics in Dermatophyte Classification and Clinical Diagnosis [DOI]
  52. 52 Human and Zoonotic Dermatophytoses: Epidemiological Aspects [DOI]
  53. 53 A Review on Antifungal Efficiency of Plant Extracts Entrenched Polysaccharide-Based Nanohydrogels [DOI]
  54. 54 Tinea pedis—An embarrassing problem for health and beauty—A narrative review [DOI]
  55. 55 Molecular Epidemiology, Genetic Diversity, and Antifungal Susceptibility of Major Pathogenic Dermatophytes Isolated From Human Dermatophytosis [DOI]
  56. 56 Changing face of epidemiology of dermatophytoses in Chinese Mainland: A 30 years nationwide retrospective study from 1991 to 2020 [DOI]
  57. 57 Survey on Dermatophytes Isolated from Animals in Switzerland in the Context of the Prevention of Zoonotic Dermatophytosis [DOI]
  58. 58 2021 Epidemiological Survey of Dermatomycoses in Japan [DOI]
  59. 59 New Antifungal Agents and New Formulations Against Dermatophytes [DOI]
  60. 60 Antifungal/Antibiotics [DOI]
  61. 61 Two Feet-One Hand Syndrome: Tinea Pedis and Tinea Manuum [DOI]
  62. 62 The investigation of dermatophyte agents in patients with dermatophytosis diagnosis [DOI]
  63. 63 Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis.
  64. 64 Synthesis, characterization and antifungal activity of a substituted coumarin and its derivatives [DOI]

Cited by 2

CLINICAL EVALUATION OF 1% OXICONAZOLE CREAM FOR DERMATOPHYTOSIS: EFFICACY AND TOLERABILITY

R. Anjum, Rijha Shahzad, W. Nusrat · Pakistan Postgraduate Medical Journal · 2026

Article metrics

Real usage data collected on this platform.

4

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.